Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous heparin infusion for PICC patency in preterm infants
IRCT20140921019250N2Phase 4Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of heparin and Normal Saline-Benha University in preterm birth (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Duration of catheter patency. Started Mar 2018; status: completed.
02
Drugs
heparinNormal Saline-Benha University
03
Conditions
preterm birth
Beyond the preview
Go deeper on IRCT20140921019250N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140921019250N2.